Skip to content
BioHarvest Sciences
  • About
    • Technology
    • Our Team
    • Contact
    • FAQ
  • Therapeutic Solutions
    • Nutraceuticals
    • CDMO Services
  • Our Competitive Advantage
    • Clinical Studies
    • Sustainability
  • News
  • Investors
BioHarvest Sciences
  • About
    • Technology
    • Our Team
    • Contact
    • FAQ
  • Therapeutic Solutions
    • Nutraceuticals
    • CDMO Services
  • Our Competitive Advantage
    • Clinical Studies
    • Sustainability
  • News
  • Investors

September 2020

BioHarvest Sciences Inc. Signs Exclusive Sales and Distribution Agreement with Batory Foods – A Leading Food Ingredients Distributor in the USA

2020 / Sam Chaloub

The deal calls for a minimum of $18.6 million (CAD) purchase of Nutraceutical ingredients in order to maintain exclusivity over the term of the Agreement. Additionally, the Agreement includes potential for future sales revenue of hemp-based CBD. Vancouver, British Columbia–(Newsfile Corp. – September 16, 2020) – BioHarvest Sciences Inc. (CSE: BHSC) (the “Company”, “BioHarvest”, “BHSC”) […]

BioHarvest Sciences Inc. Signs Exclusive Sales and Distribution Agreement with Batory Foods – A Leading Food Ingredients Distributor in the USA Read More »

Bioharvest Sciences Inc.’s Growth Strategy Progress Update Zoom Video Conference

2020 / Sam Chaloub

Bioharvest Sciences Inc.’s Growth Strategy Progress Update Zoom Video Conference Read More »

Bioharvest Sciences Inc. Closes First Tranche Of Private Placement

2020 / Sam Chaloub

Bioharvest Sciences Inc. Closes First Tranche Of Private Placement Read More »

Bioharvest Sciences Inc. Announces Private Placement

2020 / Sam Chaloub

Bioharvest Sciences Inc. Announces Private Placement Read More »

Recent Posts

  • BioHarvest Secures New CDMO Contract to Develop Plant-based Fragrance Compound
  • BioHarvest Sciences Reports First Quarter 2025 Financial Results
  • BioHarvest Announces Completion of Stage 1 Development for CDMO Contract with Nasdaq-Listed Pharmaceutical Company
  • BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time
  • BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results

Recent Comments

No comments to show.

Archives

  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • June 2020
  • April 2020

Categories

  • 2020
  • 2021
  • 2022
  • 2023
  • 2024
  • 2025
  • Uncategorized

Join Our Newsletter

Be the first to receive our news alerts, event notifications, and product releases.

Revolution
Logo
Facebook X-twitter Linkedin Youtube
  • About
    • Technology
    • Our Team
    • Contact
    • FAQ
  • Therapeutic Solutions
    • Nutraceuticals
    • CDMO Services
  • Our Competitive Advantage
    • Clinical Studies
    • Sustainability
  • News
  • Investors